Table 2.
1st author, country | Design | Rationale | Participants | Measures | Intervention | Outcomes |
---|---|---|---|---|---|---|
Huang, et al., China (2014) [32] | Randomized, double-blind, crossover, within individual patient |
Lack of sufficient evidence on effectiveness of the therapy | 1 man, 2 women, aged 18–75 years, diagnosed with stable bronchiectasis | Primary: patient self-rated symptom score for cough, expectoration, shortness of breath, chest pain and fatigue Secondary: 24-h sputum volume and drug safety |
Herbal decoction vs control decoction |
All three patients showed non-significant improvement from the test TCM. One patient preferred the herbal decoction over the standard one after trial completion |
Yuhong, et al,, China, (2012) [33] | Randomized, double-blind, crossover, within individual patient |
Lack of sufficient evidence on effectiveness of the therapy | 15 men, 35 women, aged 25–65 years, with a clinical diagnosis of deficiency of kidney-Yin | Primary: individual completion rates, response rate, and post-N-of-1 RCT decision Secondary: self-rated symptom score on Likert scale and SF-36 questionnaire to measure perceived health and quality of life |
Liuwei Dihuang decoction (LDD) vs placebo | Only 3 (6.38%) responded, 28 (59.57%) did not respond, and 16 (34.05%) were possible responders. 29 (66%) patients changed medication after the trial |
Wang et al., China (2010) [35] | Randomized, double-blind, crossover, within individual patient |
Lack of sufficient evidence on effectiveness of the therapy | 6 men, 5 women, aged 45–66 years, with diagnosis of mild-moderate hypertension | Effectiveness: change in blood pressure (home and clinic measurements) Safety: respiratory rate, heart rate, routine blood test for liver and kidney function, urine test, routine ECG |
High-dose vs low-dose Bezoar anti-hypertension capsule plus simulation placebo | Home BP measurements showed significant reduction only in SBP. Clinic BP measurements showed significant reduction both in SBP and DBP from the high-dose TCM (P < 0.001) There was no increased risk of adverse events from high-dose Bezoar |
Yu et al,, China (2012) [36] | Randomized, crossover, within individual patient |
Lack of sufficient evidence on effectiveness of the therapy | 3 men, aged 52, 57 and 59 years with diagnosis of chronic kidney disease (CKD) of third stage | Individual patient main symptom score. Change in serum creatinine and creatinine clearance rate |
Chinese medicinal decoctions plus the routine basic treatment vs only the routine basic treatment | Individual patients’ main symptom was significantly improved in the treatment phase (P < 0.01). Two patients showed improved serum creatinine and creatinine clearance rate |
Zhang, et al., China (2012) [37] | Randomized, crossover, within individual patient |
Lack of sufficient evidence on effectiveness of the therapy | 4 patients, all male, ages 50, 61, 68 and 76 years, with diagnosis of hypertensive intracerebral haemorrhage | Patient main symptoms; IL-6, morphology index and clinical curative effect evaluation (the degree of encephaloedema and cerebral infarction) | Standard treatment plus TCM, acupuncture and moxibustion; Traditional Chinese manipulation vs standard treatment plus TCM | TCM symptom scores of all patients were significantly improved (P < 0.01). IL-6 of all patients was significantly reduced (P < 0.01). Scores of Morphology Index and Clinical Curative Effect were also improved from the treatment phase |
Louly et al., Brazil (2009) [34] | Randomized, double-blind, crossover, within individual patient |
Lack of optimal therapy to treat cough in patient | 55-year-old female patient with dry cough secondary to interstitial pneumopathy |
Primary outcome: the intensity of daytime and night-time cough measured by a visual analog scale and patient’s perception regarding her health state | Tramadol 50 mg compared with placebo |
The patient’s condition as measured by visual analog scale significantly improved compared with the test drug (P < 0.001) |
BP blood pressure, DBP diastolic blood presure, RCT randomized controlled trial, SBP systolic blood pressure, TCM Traditional Chinese Medicine